Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02571725
Title PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors New Mexico Cancer Care Alliance
Indications

peritoneal carcinoma

ovarian carcinoma

fallopian tube carcinoma

Therapies

Olaparib + Tremelimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.